Understanding And Treating Schizophrenia

Two leading schizophrenia researchers present an accessible and comprehensive guide to dealing with the disease. They provide key information on the integration of drugs and psychological treatments and discuss how family members can be a helpful part of the treatment process.

Get a fair and balanced perspective on schizophrenia! Understanding and Treating Schizophrenia: Contemporary Research, Theory, and Practice is a comprehensive overview of schizophrenia and its treatment from a variety of approaches. The book presents a balanced look at the most influential theoretical perspectives based on empirical research, clinical descriptions, and narrative histories. Dr. Glenn Shean, author of Schizophrenia: An Introduction to Research and Theory, examines neurocognitive and neurodevelopmental models of brain dysfunction, psychodynamic and family factors, up-to-date pharmacological advances, and successful community programs for discharged patients suffering from this debilitating disorder. Understanding and Treating Schizophrenia: Contemporary Research, Theory, and Practice presents a comprehensive review of evidence concerning the epidemiology and course and outcome of schizophrenia based on theoretical groupings and levels of analysis. The book examines the evolution of diagnostic criteria and guidelines, as well as stress-vulnerability and diathesis-stress models, providing critical reviews of biological, genetic, cognitive-behavioral, and phenomenological, approach to understanding and treating schizophrenia. Topics addressed in Understanding and Treating Schizophrenia: Contemporary Research, Theory, and Practice include: the history of the concept of schizophrenia the writings of Emil Kraepelin and Eugene Bleuler changes in diagnostic guidelines in the last 50 years General System Theory Perspective diagnostic and statistical manuals Schneider's first rank symptoms and much more! Understanding and Treating Schizophrenia: Contemporary Research, Theory, and Practice is an essential resource for undergraduate and graduate students working in psychology, psychiatry, nursing, social work, and social policy.

This book challenges professional and public misconceptions of schizophrenia as an illness with intractable symptoms and inexorable mental deterioration, educating clinicians and researchers on the effectiveness of treatment to change the course of or prevent the onset of illness. The authors illustrate such effectiveness through fifteen case studies examining psychosis in diverse clients. These case studies are divided into the three phases of the illness—prodromal/clinical high risk, first-episode, chronic, and treatment-refractory—with accompanying analyses of the causes, symptoms, interventions and treatments. By depicting patients at different clinical stages of the illness, with accompanying explanations of how they got to that point, what might have been done to avoid – or has been done to achieve – this outcome, the reader will gain an appreciation of the nature of the illness and for the therapeutic potential of currently available treatments. Readers will learn about the various clinical aspects of schizophrenia and treatment including diagnosis, prognosis, clinical presentation, suicide risk, cognitive deficits, stigma, medication management, and psychosocial interventions.

An international team of leading researchers and clinicians here provide a comprehensive, epidemiological overview of this multi-faceted and still perplexing disorder, and address some of the key questions it raises. How important in the genetic contribution to schizophrenia? Do pregnancy and birth complications increase the risk for schizophrenia? Is the incidence of schizophrenia changing? Why is the rate higher among immigrants and in those born in cities? Controversial issues such as the validity of discrete or dimensional classifications of schizophrenia and the continuum between psychosis and 'normality' are explored in depth, and separate chapters are devoted to topics of particular relevance to schizophrenia such as suicide, violence and substance abuse. Finally, new prospects for treatment and prevention are considered. Drawing together the findings from social, genetic, developmental and classical epidemiology of schizophrenia, this text will prove an invaluable resource for clinicians and researchers.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

Reviewing the breadth of current knowledge on schizophrenia, this handbook provides clear, practical guidelines for effective assessment and treatment in diverse contexts. Leading authorities have contributed 61 concise chapters on all aspects of the disorder and its clinical management. In lieu of exhaustive literature reviews, each chapter summarizes the state of the science; highlights key points the busy practitioner needs to know; and lists recommended resources, including seminal research studies, invaluable clinical tools, and more. Comprehensive, authoritative, and timely, the volume will enable professionals in any setting to better understand and help their patients or clients with severe mental illness.

Psychosis can be associated with a variety of mental health problems, including schizophrenia, severe depression, bipolar disorder, anxiety, and post-traumatic stress disorders. While traditional treatments for psychosis have emphasized medication-based strategies, evidence now suggests that individuals affected by psychosis can greatly benefit from psychotherapy. Treating Psychosis is an evidence-based treatment guide for mental health professionals working with individuals affected by psychosis. Using a cognitive behavioral therapy (CBT) approach that incorporates acceptance and commitment therapy (ACT), compassion-focused therapy (CFT) and mindfulness approaches, this book is invaluable in helping clinicians develop effective treatment for clients affected by psychosis. The guide provides session-by-session clinical interventions for use in individual or group treatment on an inpatient, outpatient, or community basis. The book features 40 reproducible clinical practice forms and a companion website with additional downloadable clinical forms and tools, guided exercises, case examples, and resources. The therapeutic approaches presented are rooted in theory and research, and informed by extensive clinical experience working with client populations affected by psychosis. The approaches outlined in this book offer clinicians and clients the opportunity to partner in developing therapeutic strategies for problematic symptoms to enable those affected by psychosis to work toward valued goals and ultimately live more meaningful lives. This guide emphasizes a compassionate, de-stigmatizing approach that integrates empowering and strengths-oriented methods that place the client’s values and goals at the center of any therapeutic intervention.